| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Animal: RNA Viruses |
National Institute of Neuroscience, NCNP, 4-1-1 Ogawahigashi, Kodaira, Tokyo 187-8502, Japan1
National Veterinary Assay Laboratory, 1-15-1 Tokura, Kokubunji, Tokyo 185-8511, Japan2
Author for correspondence: Fumihiro Taguchi. Fax +81 423 46 1754. e-mail taguchi{at}ncnp.go.jp
The monoclonal antibody (MAb) 5B19.2, which has virus-neutralizing and fusion inhibition activities, binds to an epitope (S2A) consisting of nine hydrophobic amino acids in the S2 subunit of the mouse hepatitis virus (MHV) spike (S) protein. This suggests that the S2A epitope may be involved in binding the virus to the MHV receptor and/or in virus–cell fusion. Co-immunoprecipitation analyses demonstrated that while the binding of virus to the receptor was blocked by anti-S1 MAbs, it was not blocked by the S2A antiserum, indicating that S2A was not involved in receptor-binding. The S proteins prepared in this study with mutations in the S2A epitope were either fusogenic or non-fusogenic and their fusogenicity did not correlate with the hydrophobic feature of the S2A epitope. All of these wt and mutated S proteins were similarly transported onto the cell membrane independent of their fusogenicity capability. These results suggest that S2A may mediate the fusion activity of the MHV S protein during virus entry into cells.
This article has been cited by other articles:
|
|
 |
|
  R. Watanabe, S. Matsuyama, K. Shirato, M. Maejima, S. Fukushi, S. Morikawa, and F. Taguchi Entry from the Cell Surface of Severe Acute Respiratory Syndrome Coronavirus with Cleaved S Protein as Revealed by Pseudotype Virus Bearing Cleaved S Protein J. Virol., December 1, 2008; 82(23): 11985 - 11991. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-M. Lip, S. Shen, X. Yang, C.-T. Keng, A. Zhang, H.-L. J. Oh, Z.-H. Li, L.-A. Hwang, C.-F. Chou, B. C. Fielding, et al. Monoclonal Antibodies Targeting the HR2 Domain and the Region Immediately Upstream of the HR2 of the S Protein Neutralize In Vitro Infection of Severe Acute Respiratory Syndrome Coronavirus J. Virol., January 15, 2006; 80(2): 941 - 950. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Sainz Jr., J. M. Rausch, W. R. Gallaher, R. F. Garry, and W. C. Wimley Identification and Characterization of the Putative Fusion Peptide of the Severe Acute Respiratory Syndrome-Associated Coronavirus Spike Protein J. Virol., June 1, 2005; 79(11): 7195 - 7206. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. S. Miura, K. Nakagaki, and F. Taguchi N-Terminal Domain of the Murine Coronavirus Receptor CEACAM1 Is Responsible for Fusogenic Activation and Conformational Changes of the Spike Protein J. Virol., January 1, 2004; 78(1): 216 - 223. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Ontiveros, T. S. Kim, T. M. Gallagher, and S. Perlman Enhanced Virulence Mediated by the Murine Coronavirus, Mouse Hepatitis Virus Strain JHM, Is Associated with a Glycine at Residue 310 of the Spike Glycoprotein J. Virol., October 1, 2003; 77(19): 10260 - 10269. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Matsuyama and F. Taguchi Receptor-Induced Conformational Changes of Murine Coronavirus Spike Protein J. Virol., October 25, 2002; 76(23): 11819 - 11826. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Taguchi and S. Matsuyama Soluble Receptor Potentiates Receptor-Independent Infection by Murine Coronavirus J. Virol., February 1, 2002; 76(3): 950 - 958. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
